Persistent URL of this record https://hdl.handle.net/1887/3184643
In Collections
This item can be found in the following collections:
Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 'CaboGIST'
- All authors
- Schoffski, P.; Mir, O.; Kasper, B.; Papai, Z.; Blay, J.Y.; Italiano, A.; Benson, C.; Kopeckova, K.; Ali, N.; Dileo, P.; LeCesne, A.; Menge, F.; Cousin, S.; Wardelmann, E.; Wozniak, A.; Marreaud, S.; Litiere, S.; Zaffaroni, F.; Nzokirantevye, A.; Bempt, I.V.; Gelderblom, H.
- Date
- 2020-07-01
- Journal
- European Journal of Cancer
- Volume
- 134
- Pages
- 62 - 74